161 related articles for article (PubMed ID: 9518970)
1. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.
Yuan Z; Bowlin S; Einstadter D; Cebul RD; Conners AR; Rimm AA
Am J Public Health; 1998 Mar; 88(3):395-400. PubMed ID: 9518970
[TBL] [Abstract][Full Text] [Related]
2. Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.
Chen ML; Parikh NS; Merkler AE; Kleindorfer DO; Bhave PD; Levitan EB; Soliman EZ; Kamel H
J Am Heart Assoc; 2019 Feb; 8(4):e010661. PubMed ID: 30741594
[TBL] [Abstract][Full Text] [Related]
3. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation.
Al-Kawaz M; Omran SS; Parikh NS; Elkind MSV; Soliman EZ; Kamel H
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):839-844. PubMed ID: 29223550
[TBL] [Abstract][Full Text] [Related]
4. Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation.
Turakhia MP; Solomon MD; Jhaveri M; Davis P; Eber MR; Conrad R; Summers N; Lakdawalla D
Am Heart J; 2013 Sep; 166(3):573-80. PubMed ID: 24016509
[TBL] [Abstract][Full Text] [Related]
5. Impact of atrial fibrillation on mortality, stroke, and medical costs.
Wolf PA; Mitchell JB; Baker CS; Kannel WB; D'Agostino RB
Arch Intern Med; 1998 Feb; 158(3):229-34. PubMed ID: 9472202
[TBL] [Abstract][Full Text] [Related]
6. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study.
Yamanouchi H; Shimada H; Tomonaga M; Matsushita S
Acta Neurol Scand; 1989 Aug; 80(2):123-9. PubMed ID: 2816274
[TBL] [Abstract][Full Text] [Related]
8. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
[TBL] [Abstract][Full Text] [Related]
9. Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Graham DJ; Reichman ME; Wernecke M; Hsueh YH; Izem R; Southworth MR; Wei Y; Liao J; Goulding MR; Mott K; Chillarige Y; MaCurdy TE; Worrall C; Kelman JA
JAMA Intern Med; 2016 Nov; 176(11):1662-1671. PubMed ID: 27695821
[TBL] [Abstract][Full Text] [Related]
10. Prevention of embolic complications in nonvalvular atrial fibrillation in the elderly.
Lake FR; Thompson PL
Drugs Aging; 1991; 1(6):458-66. PubMed ID: 1794032
[TBL] [Abstract][Full Text] [Related]
11. Perioperative atrial fibrillation and the long-term risk of ischemic stroke.
Gialdini G; Nearing K; Bhave PD; Bonuccelli U; Iadecola C; Healey JS; Kamel H
JAMA; 2014 Aug; 312(6):616-22. PubMed ID: 25117130
[TBL] [Abstract][Full Text] [Related]
12. Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
Ogata T; Matsuo R; Kiyuna F; Hata J; Ago T; Tsuboi Y; Kitazono T; Kamouchi M;
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862939
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors.
Walkey AJ; Greiner MA; Heckbert SR; Jensen PN; Piccini JP; Sinner MF; Curtis LH; Benjamin EJ
Am Heart J; 2013 Jun; 165(6):949-955.e3. PubMed ID: 23708166
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.
Flegel KM; Hanley J
Stroke; 1989 Aug; 20(8):1000-4. PubMed ID: 2756532
[TBL] [Abstract][Full Text] [Related]
15. Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly.
Yamanouchi H; Tomonaga M; Shimada H; Matsushita S; Kuramoto K; Toyokura Y
Stroke; 1989 Dec; 20(12):1653-6. PubMed ID: 2595728
[TBL] [Abstract][Full Text] [Related]
16. Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction.
Eapen ZJ; Greiner MA; Fonarow GC; Yuan Z; Mills RM; Hernandez AF; Curtis LH
Am Heart J; 2014 Mar; 167(3):369-375.e2. PubMed ID: 24576522
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
18. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
19. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
20. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
